Global Recombinant FVIII Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Recombinant FVIII
According to our (Global Info Research) latest study, the global Recombinant FVIII market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Recombinant FVIII market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Recombinant FVIII market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Recombinant FVIII market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Recombinant FVIII market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Recombinant FVIII market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant FVIII
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant FVIII market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Baxter, Comirnaty, Novo Nordisk and Green Cross and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Recombinant FVIII market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Recombinant FVIII product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant FVIII, with price, sales, revenue and global market share of Recombinant FVIII from 2018 to 2023.
Chapter 3, the Recombinant FVIII competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant FVIII breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Recombinant FVIII market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant FVIII.
Chapter 14 and 15, to describe Recombinant FVIII sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Recombinant FVIII market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Recombinant FVIII market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Recombinant FVIII market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Recombinant FVIII market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Recombinant FVIII market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Recombinant FVIII market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant FVIII
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant FVIII market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Baxter, Comirnaty, Novo Nordisk and Green Cross and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Recombinant FVIII market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 250 IU/bottle
- 500 IU/bottle
- 1000 IU/bottle
- 2000 IU/bottle
- Teenagers
- Adults
- Bayer
- Baxter
- Comirnaty
- Novo Nordisk
- Green Cross
- Sinocelltech
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Recombinant FVIII product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant FVIII, with price, sales, revenue and global market share of Recombinant FVIII from 2018 to 2023.
Chapter 3, the Recombinant FVIII competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant FVIII breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Recombinant FVIII market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant FVIII.
Chapter 14 and 15, to describe Recombinant FVIII sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Recombinant FVIII
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombinant FVIII Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 250 IU/bottle
1.3.3 500 IU/bottle
1.3.4 1000 IU/bottle
1.3.5 2000 IU/bottle
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombinant FVIII Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Teenagers
1.4.3 Adults
1.5 Global Recombinant FVIII Market Size & Forecast
1.5.1 Global Recombinant FVIII Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Recombinant FVIII Sales Quantity (2018-2029)
1.5.3 Global Recombinant FVIII Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Recombinant FVIII Product and Services
2.1.4 Bayer Recombinant FVIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Recent Developments/Updates
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business
2.2.3 Baxter Recombinant FVIII Product and Services
2.2.4 Baxter Recombinant FVIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Baxter Recent Developments/Updates
2.3 Comirnaty
2.3.1 Comirnaty Details
2.3.2 Comirnaty Major Business
2.3.3 Comirnaty Recombinant FVIII Product and Services
2.3.4 Comirnaty Recombinant FVIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Comirnaty Recent Developments/Updates
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Recombinant FVIII Product and Services
2.4.4 Novo Nordisk Recombinant FVIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novo Nordisk Recent Developments/Updates
2.5 Green Cross
2.5.1 Green Cross Details
2.5.2 Green Cross Major Business
2.5.3 Green Cross Recombinant FVIII Product and Services
2.5.4 Green Cross Recombinant FVIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Green Cross Recent Developments/Updates
2.6 Sinocelltech
2.6.1 Sinocelltech Details
2.6.2 Sinocelltech Major Business
2.6.3 Sinocelltech Recombinant FVIII Product and Services
2.6.4 Sinocelltech Recombinant FVIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sinocelltech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RECOMBINANT FVIII BY MANUFACTURER
3.1 Global Recombinant FVIII Sales Quantity by Manufacturer (2018-2023)
3.2 Global Recombinant FVIII Revenue by Manufacturer (2018-2023)
3.3 Global Recombinant FVIII Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Recombinant FVIII by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Recombinant FVIII Manufacturer Market Share in 2022
3.4.2 Top 6 Recombinant FVIII Manufacturer Market Share in 2022
3.5 Recombinant FVIII Market: Overall Company Footprint Analysis
3.5.1 Recombinant FVIII Market: Region Footprint
3.5.2 Recombinant FVIII Market: Company Product Type Footprint
3.5.3 Recombinant FVIII Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Recombinant FVIII Market Size by Region
4.1.1 Global Recombinant FVIII Sales Quantity by Region (2018-2029)
4.1.2 Global Recombinant FVIII Consumption Value by Region (2018-2029)
4.1.3 Global Recombinant FVIII Average Price by Region (2018-2029)
4.2 North America Recombinant FVIII Consumption Value (2018-2029)
4.3 Europe Recombinant FVIII Consumption Value (2018-2029)
4.4 Asia-Pacific Recombinant FVIII Consumption Value (2018-2029)
4.5 South America Recombinant FVIII Consumption Value (2018-2029)
4.6 Middle East and Africa Recombinant FVIII Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Recombinant FVIII Sales Quantity by Type (2018-2029)
5.2 Global Recombinant FVIII Consumption Value by Type (2018-2029)
5.3 Global Recombinant FVIII Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Recombinant FVIII Sales Quantity by Application (2018-2029)
6.2 Global Recombinant FVIII Consumption Value by Application (2018-2029)
6.3 Global Recombinant FVIII Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Recombinant FVIII Sales Quantity by Type (2018-2029)
7.2 North America Recombinant FVIII Sales Quantity by Application (2018-2029)
7.3 North America Recombinant FVIII Market Size by Country
7.3.1 North America Recombinant FVIII Sales Quantity by Country (2018-2029)
7.3.2 North America Recombinant FVIII Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Recombinant FVIII Sales Quantity by Type (2018-2029)
8.2 Europe Recombinant FVIII Sales Quantity by Application (2018-2029)
8.3 Europe Recombinant FVIII Market Size by Country
8.3.1 Europe Recombinant FVIII Sales Quantity by Country (2018-2029)
8.3.2 Europe Recombinant FVIII Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Recombinant FVIII Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Recombinant FVIII Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Recombinant FVIII Market Size by Region
9.3.1 Asia-Pacific Recombinant FVIII Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Recombinant FVIII Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Recombinant FVIII Sales Quantity by Type (2018-2029)
10.2 South America Recombinant FVIII Sales Quantity by Application (2018-2029)
10.3 South America Recombinant FVIII Market Size by Country
10.3.1 South America Recombinant FVIII Sales Quantity by Country (2018-2029)
10.3.2 South America Recombinant FVIII Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Recombinant FVIII Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Recombinant FVIII Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Recombinant FVIII Market Size by Country
11.3.1 Middle East & Africa Recombinant FVIII Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Recombinant FVIII Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Recombinant FVIII Market Drivers
12.2 Recombinant FVIII Market Restraints
12.3 Recombinant FVIII Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Recombinant FVIII and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant FVIII
13.3 Recombinant FVIII Production Process
13.4 Recombinant FVIII Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant FVIII Typical Distributors
14.3 Recombinant FVIII Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Recombinant FVIII
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombinant FVIII Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 250 IU/bottle
1.3.3 500 IU/bottle
1.3.4 1000 IU/bottle
1.3.5 2000 IU/bottle
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombinant FVIII Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Teenagers
1.4.3 Adults
1.5 Global Recombinant FVIII Market Size & Forecast
1.5.1 Global Recombinant FVIII Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Recombinant FVIII Sales Quantity (2018-2029)
1.5.3 Global Recombinant FVIII Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Recombinant FVIII Product and Services
2.1.4 Bayer Recombinant FVIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Recent Developments/Updates
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business
2.2.3 Baxter Recombinant FVIII Product and Services
2.2.4 Baxter Recombinant FVIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Baxter Recent Developments/Updates
2.3 Comirnaty
2.3.1 Comirnaty Details
2.3.2 Comirnaty Major Business
2.3.3 Comirnaty Recombinant FVIII Product and Services
2.3.4 Comirnaty Recombinant FVIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Comirnaty Recent Developments/Updates
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Recombinant FVIII Product and Services
2.4.4 Novo Nordisk Recombinant FVIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novo Nordisk Recent Developments/Updates
2.5 Green Cross
2.5.1 Green Cross Details
2.5.2 Green Cross Major Business
2.5.3 Green Cross Recombinant FVIII Product and Services
2.5.4 Green Cross Recombinant FVIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Green Cross Recent Developments/Updates
2.6 Sinocelltech
2.6.1 Sinocelltech Details
2.6.2 Sinocelltech Major Business
2.6.3 Sinocelltech Recombinant FVIII Product and Services
2.6.4 Sinocelltech Recombinant FVIII Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sinocelltech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RECOMBINANT FVIII BY MANUFACTURER
3.1 Global Recombinant FVIII Sales Quantity by Manufacturer (2018-2023)
3.2 Global Recombinant FVIII Revenue by Manufacturer (2018-2023)
3.3 Global Recombinant FVIII Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Recombinant FVIII by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Recombinant FVIII Manufacturer Market Share in 2022
3.4.2 Top 6 Recombinant FVIII Manufacturer Market Share in 2022
3.5 Recombinant FVIII Market: Overall Company Footprint Analysis
3.5.1 Recombinant FVIII Market: Region Footprint
3.5.2 Recombinant FVIII Market: Company Product Type Footprint
3.5.3 Recombinant FVIII Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Recombinant FVIII Market Size by Region
4.1.1 Global Recombinant FVIII Sales Quantity by Region (2018-2029)
4.1.2 Global Recombinant FVIII Consumption Value by Region (2018-2029)
4.1.3 Global Recombinant FVIII Average Price by Region (2018-2029)
4.2 North America Recombinant FVIII Consumption Value (2018-2029)
4.3 Europe Recombinant FVIII Consumption Value (2018-2029)
4.4 Asia-Pacific Recombinant FVIII Consumption Value (2018-2029)
4.5 South America Recombinant FVIII Consumption Value (2018-2029)
4.6 Middle East and Africa Recombinant FVIII Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Recombinant FVIII Sales Quantity by Type (2018-2029)
5.2 Global Recombinant FVIII Consumption Value by Type (2018-2029)
5.3 Global Recombinant FVIII Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Recombinant FVIII Sales Quantity by Application (2018-2029)
6.2 Global Recombinant FVIII Consumption Value by Application (2018-2029)
6.3 Global Recombinant FVIII Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Recombinant FVIII Sales Quantity by Type (2018-2029)
7.2 North America Recombinant FVIII Sales Quantity by Application (2018-2029)
7.3 North America Recombinant FVIII Market Size by Country
7.3.1 North America Recombinant FVIII Sales Quantity by Country (2018-2029)
7.3.2 North America Recombinant FVIII Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Recombinant FVIII Sales Quantity by Type (2018-2029)
8.2 Europe Recombinant FVIII Sales Quantity by Application (2018-2029)
8.3 Europe Recombinant FVIII Market Size by Country
8.3.1 Europe Recombinant FVIII Sales Quantity by Country (2018-2029)
8.3.2 Europe Recombinant FVIII Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Recombinant FVIII Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Recombinant FVIII Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Recombinant FVIII Market Size by Region
9.3.1 Asia-Pacific Recombinant FVIII Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Recombinant FVIII Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Recombinant FVIII Sales Quantity by Type (2018-2029)
10.2 South America Recombinant FVIII Sales Quantity by Application (2018-2029)
10.3 South America Recombinant FVIII Market Size by Country
10.3.1 South America Recombinant FVIII Sales Quantity by Country (2018-2029)
10.3.2 South America Recombinant FVIII Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Recombinant FVIII Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Recombinant FVIII Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Recombinant FVIII Market Size by Country
11.3.1 Middle East & Africa Recombinant FVIII Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Recombinant FVIII Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Recombinant FVIII Market Drivers
12.2 Recombinant FVIII Market Restraints
12.3 Recombinant FVIII Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Recombinant FVIII and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant FVIII
13.3 Recombinant FVIII Production Process
13.4 Recombinant FVIII Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant FVIII Typical Distributors
14.3 Recombinant FVIII Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Recombinant FVIII Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Recombinant FVIII Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Recombinant FVIII Product and Services
Table 6. Bayer Recombinant FVIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer Recent Developments/Updates
Table 8. Baxter Basic Information, Manufacturing Base and Competitors
Table 9. Baxter Major Business
Table 10. Baxter Recombinant FVIII Product and Services
Table 11. Baxter Recombinant FVIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Baxter Recent Developments/Updates
Table 13. Comirnaty Basic Information, Manufacturing Base and Competitors
Table 14. Comirnaty Major Business
Table 15. Comirnaty Recombinant FVIII Product and Services
Table 16. Comirnaty Recombinant FVIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Comirnaty Recent Developments/Updates
Table 18. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 19. Novo Nordisk Major Business
Table 20. Novo Nordisk Recombinant FVIII Product and Services
Table 21. Novo Nordisk Recombinant FVIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novo Nordisk Recent Developments/Updates
Table 23. Green Cross Basic Information, Manufacturing Base and Competitors
Table 24. Green Cross Major Business
Table 25. Green Cross Recombinant FVIII Product and Services
Table 26. Green Cross Recombinant FVIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Green Cross Recent Developments/Updates
Table 28. Sinocelltech Basic Information, Manufacturing Base and Competitors
Table 29. Sinocelltech Major Business
Table 30. Sinocelltech Recombinant FVIII Product and Services
Table 31. Sinocelltech Recombinant FVIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sinocelltech Recent Developments/Updates
Table 33. Global Recombinant FVIII Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Recombinant FVIII Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Recombinant FVIII Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 36. Market Position of Manufacturers in Recombinant FVIII, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Recombinant FVIII Production Site of Key Manufacturer
Table 38. Recombinant FVIII Market: Company Product Type Footprint
Table 39. Recombinant FVIII Market: Company Product Application Footprint
Table 40. Recombinant FVIII New Market Entrants and Barriers to Market Entry
Table 41. Recombinant FVIII Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Recombinant FVIII Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Recombinant FVIII Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Recombinant FVIII Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Recombinant FVIII Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Recombinant FVIII Average Price by Region (2018-2023) & (USD/Unit)
Table 47. Global Recombinant FVIII Average Price by Region (2024-2029) & (USD/Unit)
Table 48. Global Recombinant FVIII Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Recombinant FVIII Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Recombinant FVIII Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Recombinant FVIII Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Recombinant FVIII Average Price by Type (2018-2023) & (USD/Unit)
Table 53. Global Recombinant FVIII Average Price by Type (2024-2029) & (USD/Unit)
Table 54. Global Recombinant FVIII Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Recombinant FVIII Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Recombinant FVIII Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Recombinant FVIII Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Recombinant FVIII Average Price by Application (2018-2023) & (USD/Unit)
Table 59. Global Recombinant FVIII Average Price by Application (2024-2029) & (USD/Unit)
Table 60. North America Recombinant FVIII Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Recombinant FVIII Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Recombinant FVIII Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Recombinant FVIII Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Recombinant FVIII Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Recombinant FVIII Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Recombinant FVIII Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Recombinant FVIII Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Recombinant FVIII Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Recombinant FVIII Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Recombinant FVIII Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Recombinant FVIII Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Recombinant FVIII Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Recombinant FVIII Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Recombinant FVIII Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Recombinant FVIII Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Recombinant FVIII Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Recombinant FVIII Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Recombinant FVIII Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Recombinant FVIII Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Recombinant FVIII Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Recombinant FVIII Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Recombinant FVIII Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Recombinant FVIII Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Recombinant FVIII Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Recombinant FVIII Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Recombinant FVIII Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Recombinant FVIII Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Recombinant FVIII Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Recombinant FVIII Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Recombinant FVIII Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Recombinant FVIII Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Recombinant FVIII Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Recombinant FVIII Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Recombinant FVIII Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Recombinant FVIII Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Recombinant FVIII Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Recombinant FVIII Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Recombinant FVIII Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Recombinant FVIII Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Recombinant FVIII Raw Material
Table 101. Key Manufacturers of Recombinant FVIII Raw Materials
Table 102. Recombinant FVIII Typical Distributors
Table 103. Recombinant FVIII Typical Customers
Table 1. Global Recombinant FVIII Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Recombinant FVIII Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Recombinant FVIII Product and Services
Table 6. Bayer Recombinant FVIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer Recent Developments/Updates
Table 8. Baxter Basic Information, Manufacturing Base and Competitors
Table 9. Baxter Major Business
Table 10. Baxter Recombinant FVIII Product and Services
Table 11. Baxter Recombinant FVIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Baxter Recent Developments/Updates
Table 13. Comirnaty Basic Information, Manufacturing Base and Competitors
Table 14. Comirnaty Major Business
Table 15. Comirnaty Recombinant FVIII Product and Services
Table 16. Comirnaty Recombinant FVIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Comirnaty Recent Developments/Updates
Table 18. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 19. Novo Nordisk Major Business
Table 20. Novo Nordisk Recombinant FVIII Product and Services
Table 21. Novo Nordisk Recombinant FVIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novo Nordisk Recent Developments/Updates
Table 23. Green Cross Basic Information, Manufacturing Base and Competitors
Table 24. Green Cross Major Business
Table 25. Green Cross Recombinant FVIII Product and Services
Table 26. Green Cross Recombinant FVIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Green Cross Recent Developments/Updates
Table 28. Sinocelltech Basic Information, Manufacturing Base and Competitors
Table 29. Sinocelltech Major Business
Table 30. Sinocelltech Recombinant FVIII Product and Services
Table 31. Sinocelltech Recombinant FVIII Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sinocelltech Recent Developments/Updates
Table 33. Global Recombinant FVIII Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Recombinant FVIII Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Recombinant FVIII Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 36. Market Position of Manufacturers in Recombinant FVIII, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Recombinant FVIII Production Site of Key Manufacturer
Table 38. Recombinant FVIII Market: Company Product Type Footprint
Table 39. Recombinant FVIII Market: Company Product Application Footprint
Table 40. Recombinant FVIII New Market Entrants and Barriers to Market Entry
Table 41. Recombinant FVIII Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Recombinant FVIII Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Recombinant FVIII Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Recombinant FVIII Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Recombinant FVIII Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Recombinant FVIII Average Price by Region (2018-2023) & (USD/Unit)
Table 47. Global Recombinant FVIII Average Price by Region (2024-2029) & (USD/Unit)
Table 48. Global Recombinant FVIII Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Recombinant FVIII Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Recombinant FVIII Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Recombinant FVIII Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Recombinant FVIII Average Price by Type (2018-2023) & (USD/Unit)
Table 53. Global Recombinant FVIII Average Price by Type (2024-2029) & (USD/Unit)
Table 54. Global Recombinant FVIII Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Recombinant FVIII Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Recombinant FVIII Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Recombinant FVIII Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Recombinant FVIII Average Price by Application (2018-2023) & (USD/Unit)
Table 59. Global Recombinant FVIII Average Price by Application (2024-2029) & (USD/Unit)
Table 60. North America Recombinant FVIII Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Recombinant FVIII Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Recombinant FVIII Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Recombinant FVIII Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Recombinant FVIII Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Recombinant FVIII Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Recombinant FVIII Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Recombinant FVIII Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Recombinant FVIII Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Recombinant FVIII Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Recombinant FVIII Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Recombinant FVIII Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Recombinant FVIII Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Recombinant FVIII Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Recombinant FVIII Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Recombinant FVIII Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Recombinant FVIII Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Recombinant FVIII Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Recombinant FVIII Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Recombinant FVIII Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Recombinant FVIII Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Recombinant FVIII Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Recombinant FVIII Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Recombinant FVIII Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Recombinant FVIII Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Recombinant FVIII Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Recombinant FVIII Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Recombinant FVIII Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Recombinant FVIII Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Recombinant FVIII Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Recombinant FVIII Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Recombinant FVIII Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Recombinant FVIII Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Recombinant FVIII Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Recombinant FVIII Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Recombinant FVIII Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Recombinant FVIII Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Recombinant FVIII Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Recombinant FVIII Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Recombinant FVIII Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Recombinant FVIII Raw Material
Table 101. Key Manufacturers of Recombinant FVIII Raw Materials
Table 102. Recombinant FVIII Typical Distributors
Table 103. Recombinant FVIII Typical Customers
LIST OF FIGURES
Figure 1. Recombinant FVIII Picture
Figure 2. Global Recombinant FVIII Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Recombinant FVIII Consumption Value Market Share by Type in 2022
Figure 4. 250 IU/bottle Examples
Figure 5. 500 IU/bottle Examples
Figure 6. 1000 IU/bottle Examples
Figure 7. 2000 IU/bottle Examples
Figure 8. Global Recombinant FVIII Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Recombinant FVIII Consumption Value Market Share by Application in 2022
Figure 10. Teenagers Examples
Figure 11. Adults Examples
Figure 12. Global Recombinant FVIII Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Recombinant FVIII Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Recombinant FVIII Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Recombinant FVIII Average Price (2018-2029) & (USD/Unit)
Figure 16. Global Recombinant FVIII Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Recombinant FVIII Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Recombinant FVIII by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Recombinant FVIII Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Recombinant FVIII Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Recombinant FVIII Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Recombinant FVIII Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Recombinant FVIII Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Recombinant FVIII Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Recombinant FVIII Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Recombinant FVIII Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Recombinant FVIII Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Recombinant FVIII Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Recombinant FVIII Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Recombinant FVIII Average Price by Type (2018-2029) & (USD/Unit)
Figure 31. Global Recombinant FVIII Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Recombinant FVIII Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Recombinant FVIII Average Price by Application (2018-2029) & (USD/Unit)
Figure 34. North America Recombinant FVIII Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Recombinant FVIII Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Recombinant FVIII Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Recombinant FVIII Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Recombinant FVIII Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Recombinant FVIII Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Recombinant FVIII Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Recombinant FVIII Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Recombinant FVIII Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Recombinant FVIII Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Recombinant FVIII Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Recombinant FVIII Consumption Value Market Share by Region (2018-2029)
Figure 54. China Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Recombinant FVIII Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Recombinant FVIII Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Recombinant FVIII Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Recombinant FVIII Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Recombinant FVIII Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Recombinant FVIII Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Recombinant FVIII Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Recombinant FVIII Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Recombinant FVIII Market Drivers
Figure 75. Recombinant FVIII Market Restraints
Figure 76. Recombinant FVIII Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Recombinant FVIII in 2022
Figure 79. Manufacturing Process Analysis of Recombinant FVIII
Figure 80. Recombinant FVIII Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Recombinant FVIII Picture
Figure 2. Global Recombinant FVIII Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Recombinant FVIII Consumption Value Market Share by Type in 2022
Figure 4. 250 IU/bottle Examples
Figure 5. 500 IU/bottle Examples
Figure 6. 1000 IU/bottle Examples
Figure 7. 2000 IU/bottle Examples
Figure 8. Global Recombinant FVIII Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Recombinant FVIII Consumption Value Market Share by Application in 2022
Figure 10. Teenagers Examples
Figure 11. Adults Examples
Figure 12. Global Recombinant FVIII Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Recombinant FVIII Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Recombinant FVIII Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Recombinant FVIII Average Price (2018-2029) & (USD/Unit)
Figure 16. Global Recombinant FVIII Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Recombinant FVIII Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Recombinant FVIII by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Recombinant FVIII Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Recombinant FVIII Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Recombinant FVIII Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Recombinant FVIII Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Recombinant FVIII Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Recombinant FVIII Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Recombinant FVIII Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Recombinant FVIII Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Recombinant FVIII Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Recombinant FVIII Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Recombinant FVIII Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Recombinant FVIII Average Price by Type (2018-2029) & (USD/Unit)
Figure 31. Global Recombinant FVIII Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Recombinant FVIII Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Recombinant FVIII Average Price by Application (2018-2029) & (USD/Unit)
Figure 34. North America Recombinant FVIII Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Recombinant FVIII Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Recombinant FVIII Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Recombinant FVIII Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Recombinant FVIII Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Recombinant FVIII Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Recombinant FVIII Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Recombinant FVIII Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Recombinant FVIII Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Recombinant FVIII Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Recombinant FVIII Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Recombinant FVIII Consumption Value Market Share by Region (2018-2029)
Figure 54. China Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Recombinant FVIII Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Recombinant FVIII Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Recombinant FVIII Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Recombinant FVIII Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Recombinant FVIII Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Recombinant FVIII Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Recombinant FVIII Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Recombinant FVIII Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Recombinant FVIII Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Recombinant FVIII Market Drivers
Figure 75. Recombinant FVIII Market Restraints
Figure 76. Recombinant FVIII Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Recombinant FVIII in 2022
Figure 79. Manufacturing Process Analysis of Recombinant FVIII
Figure 80. Recombinant FVIII Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
